Literature DB >> 25192662

Distinct lymphocytes subsets in IgM-related neuropathy: clinical-immunological correlations.

Raffaele Iorio1, Mario Sabatelli, Alessandra Del Grande, Giulia Bisogni, Valentina Damato, Domenico Plantone, Alessandro Marti, Giovanni Frisullo, Angela Romano, Paolo Maria Rossini, Marco Luigetti.   

Abstract

IgM-related neuropathy generally presents as a late-onset demyelinating polyneuropathy with predominant sensory loss and ataxia. However, we recently reported the clinical, neurophysiological and pathological findings from our cohort and identified in about a third of patients an atypical phenotype. We analyzed by flow cytometry the different lymphocytes subsets in the peripheral blood of patients affected by IgM-related neuropathy, chronic inflammatory demyelinating polyneuropathy (CIDP), monoclonal gammopathy of undetermined significance and healthy subjects, to investigate whether different immunological patterns may differentiate the classical phenotype from atypical forms. IFN-gamma producing CD4+ and CD8+ T lymphocytes, as well as CD4+ and CD8+ T cells expressing T-bet (T-helper type 1, Th1) were increased in CIDP patients. The percentage of circulating CD4+ and CD8+ T cells producing IL-10 as well as the percentage of CD19+ cells expressing Blimp-1 were higher in patients with IgM-neuropathy. We did not find any significant differences in the different lymphocytes subsets in the IgM-related neuropathy between patients with classical and atypical phenotype. Th1 cells are increased in CIDP patients while a T helper type 2-phenotype seems to prevail in patients with IgM-neuropathy. Further studies involving a larger patient population are needed to evaluate if different lymphocytes subset may be involved in different clinical phenotypes of IgM-related neuropathy.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25192662     DOI: 10.1007/s10072-014-1935-x

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  21 in total

1.  Vasculitic neuropathy in a patient with cryoglobulinemia and anti-MAG IGM monoclonal gammopathy.

Authors:  F P Thomas; R E Lovelace; X S Ding; S A Sadiq; G W Petty; W H Sherman; N Latov; A P Hays
Journal:  Muscle Nerve       Date:  1992-08       Impact factor: 3.217

2.  European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society - first revision.

Authors:  P Y K Van den Bergh; R D M Hadden; P Bouche; D R Cornblath; A Hahn; I Illa; C L Koski; J-M Léger; E Nobile-Orazio; J Pollard; C Sommer; P A van Doorn; I N van Schaik
Journal:  Eur J Neurol       Date:  2010-03       Impact factor: 6.089

3.  Waldenström's macroglobulinemia and peripheral neuropathy: deposition of M-component and kappa light chain in the endoneurium.

Authors:  C Vital; C Deminière; B Bourgouin; A Lagueny; B David; P Loiseau
Journal:  Neurology       Date:  1985-04       Impact factor: 9.910

4.  Long-term prognosis of neuropathy associated with anti-MAG IgM M-proteins and its relationship to immune therapies.

Authors:  E Nobile-Orazio; N Meucci; L Baldini; A Di Troia; G Scarlato
Journal:  Brain       Date:  2000-04       Impact factor: 13.501

5.  Neuropathy with predominant small fiber involvement associated with abnormal anti-MAG titer.

Authors:  Marco Luigetti; Francesca Madia; Amelia Conte; Pietro Tonali; Mario Sabatelli
Journal:  Intern Med       Date:  2010-12-01       Impact factor: 1.271

6.  Clinical and pathological heterogeneity in a series of 31 patients with IgM-related neuropathy.

Authors:  M Luigetti; A Conte; N Montano; A Del Grande; F Madia; M Lo Monaco; L Laurenti; M Sabatelli
Journal:  J Neurol Sci       Date:  2012-05-25       Impact factor: 3.181

7.  Distinct cytokine patterns associated with different forms of chronic dysimmune neuropathy.

Authors:  Maira Gironi; Marina Saresella; Ivana Marventano; Franca Rosa Guerini; Andrea Gatti; Giovanni Antonini; Lara Ceresa; Stefania Morino; Ettore Beghi; Alberto Angelici; Enrica Mariani; Raffaello Nemni; Mario Clerici
Journal:  Muscle Nerve       Date:  2010-12       Impact factor: 3.217

8.  IgM MGUS anti-MAG neuropathy with predominant muscle weakness and extensive muscle atrophy.

Authors:  Yuichi Kawagashira; Naohide Kondo; Naoki Atsuta; Masahiro Iijima; Haruki Koike; Masahisa Katsuno; Fumiaki Tanaka; Susumu Kusunoki; Gen Sobue
Journal:  Muscle Nerve       Date:  2010-09       Impact factor: 3.217

9.  Peripheral neuropathy in monoclonal gammopathy of undetermined significance: prevalence and immunopathogenetic studies.

Authors:  E Nobile-Orazio; S Barbieri; L Baldini; P Marmiroli; M Carpo; S Premoselli; E Manfredini; G Scarlato
Journal:  Acta Neurol Scand       Date:  1992-06       Impact factor: 3.209

10.  Persistence of abnormal electrophysiological findings after carpal tunnel release.

Authors:  Antonio Merolli; Marco Luigetti; Anna Modoni; Marcella Masciullo; Maria Lucia Mereu; Mauro Lo Monaco
Journal:  J Reconstr Microsurg       Date:  2013-06-11       Impact factor: 2.873

View more
  1 in total

1.  An observational study assessing peripheral neuropathy related to multiple myeloma.

Authors:  C Leone; V Federico; S La Cesa; E Russo; G Di Stefano; P Finsinger; R Labriola; G Cruccu; M T Petrucci; A Truini
Journal:  Neurol Sci       Date:  2016-03-09       Impact factor: 3.307

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.